TY  - GEN
AU  - Santos, C
AU  - Azuara, D
AU  - Vieitez, JM
AU  - Paez, D
AU  - Falcó, Esther
AU  - Elez, Elena
AU  - Lopez-Lopez, C
AU  - Valladares, M
AU  - Robles-Diaz, L
AU  - Garcia-Alfonso, P
AU  - Buges, C
AU  - Duran, Gema
AU  - Salud, A
AU  - Navarro, V
AU  - Capella, G
AU  - Aranda, E
AU  - Salazar, R
AU  - Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
PY  - 2019
DO  - 10.1093/annonc/mdz082
SN  - 0923-7534
UR  - https://hdl.handle.net/20.500.12105/22782
AB  - Background: Several studies show the importance of accurately quantifying not only KRAS and other low-abundant mutations because benefits of anti-EGFR therapies may depend on certain sensitivity thresholds. We assessed whether ultra-selection of...
LA  - eng
PB  - Oxford University Press
KW  - Digital PCR
KW  - FOLFIRI
KW  - Metastatic colorectal cancer
KW  - Panitumumab
KW  - Patient selection
KW  - PCR
TI  - Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
TY  - research article
ER  -